RoslinCT is a leading Cell Therapy Contract Development and Manufacturing Organisation (CDMO) enabling you to bring your autologous or allogeneic therapy safely to the patient. Our service offering includes process development, technology transfer, GMP manufacture and batch release of cell-based therapies and Advanced Therapy Medicinal Products (ATMP’s).

At the heart of RoslinCT is a dynamic, highly experienced team that will understand your goals and will partner with you to get your therapy to market efficiently and effectively. Based at the Edinburgh BioQuarter, we operate a fully licensed GMP manufacturing facility and have a proven track record in the delivery of cell-based products.

At RoslinCT we strive to provide superior development and manufacturing services, combined with expert advice, value and support at every stage to those bringing the next generation advanced therapies to patients. This together with a passion for innovation and a flexible and personalised approach enables RoslinCT to support clients at every step of the cell therapy development journey.